Project Grant R21NS142585
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$461K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 24-month, $430,375 Project Grant (CFDA 93.853) to Emory University to develop human organoid models for pediatric high-grade gliomas (PHGGs). The research aims to 1) create PHGG organoid models using human patient-derived cancer stem cells and 2) model how interactions between PHGG cells and the human neural microenvironment affect responses to tyrosine kinase inhibitors and other anti-tumor drugs. The goal is to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to determine the origins and vulnerabilities of pediatric treatment-induced gliomas, also known as radiation-induced gliomas (RIGs). The $474,337 award will fund a 5-year project to discover germline risk factors for RIGs, identify key tumor growth pathways and...
This $416,265 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to understand the impact of low-grade glioma infiltration on cortical structure and function. The key objectives are to: 1) Define the effects of glioma on cortical neuron laminar structure and excitatory-inhibitory signaling; 2) Determine the functional...
This $443,354 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate metabolic dependencies and resistance mechanisms in pediatric diffuse midline glioma (DMG) brain tumors harboring the H3K27M mutation. The research aims to understand how targeting the hexosamine biosynthetic pathway, either alone or in...
This $687,279 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research to dissect the immune responses and cellular composition within the tumor microenvironment of glioblastoma (GBM). The project aims to leverage spatial transcriptomics and proteomics analysis of archival human GBM samples and mouse models to uncover the effects...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports research to develop mRNA-based gene therapies for treating pediatric high-grade gliomas, particularly diffuse midline glioma (DMG). The $142,452 award, effective from Sep 18, 2024 to Aug 31, 2026, aims to optimize the delivery of mRNA using lipid nanoparticles to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $190,485 to Indiana University Indianapolis to investigate the molecular mechanisms underlying differentiation failure in neuroepithelial stem cells with NF2 gene mutations. The goal is to identify the cellular hierarchy and dysregulated signaling pathways in these...
This federal Project Grant award of $877,001 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to elucidate the cellular and molecular mechanisms underlying the clinical heterogeneity of neurofibromatosis type 1 (NF1). The awardee, The Washington University, will leverage patient-derived and CRISPR-engineered human induced pluripotent stem cells,...
This Project Grant award for $676,388.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant supports research at St. Jude Children's Research Hospital to explore how proteins involved in controlling neuronal migration and polarity also impact chromatin organization and neuronal differentiation during brain development. The research...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $448,250 to The Research Foundation For The State University Of New York (Upstate Medical Center) to support research focused on disrupting radioresistance in glioblastoma, an aggressive brain cancer, by targeting scaffolding proteins. The project aims to characterize how genetic...